Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.38 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.32 |
| ▸ | MYC | P01106 | 1/20 | 0.32 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.32 |
| ▸ | MAP2K3 | P46734 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22014739 | 0.86 | NLRP3 (0.33) | NLRP3GABRA1GABRG2GABRB3 | |
| SCHEMBL30276820 | 0.86 | NLRP3 (0.33) | NLRP3GABRA1GABRG2GABRB3 | |
| SCHEMBL21962160 | 0.85 | KDM4E (0.33) | NLRP3GABRA1GABRG2GABRB3 | |
| SCHEMBL21962238 | 0.84 | NLRP3 (0.33) | NLRP3GABRA1GABRG2GABRB3 | |
| SCHEMBL25067068 | 0.70 | NLRP3 (0.39) | NLRP3 | |
| SCHEMBL25067070 | 0.70 | NLRP3 (0.39) | NLRP3 | |
| SCHEMBL16843335 | 0.67 | — | — | |
| SCHEMBL20028908 | 0.67 | GABRA1 (0.30) | GABRA1GABRG2GABRB3 | |
| SCHEMBL8859174 | 0.66 | FABP3 (0.33) | — | |
| SCHEMBL24192685 | 0.65 | ADORA2A (0.34) | ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020102574-A1 | THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS INFLAMMASOME RESEARCH, INC. (US) | 2020-05-22 | — | — | WO | disclosed |